Technology

Virtual Family Behavioral Health: Digital care solutions that help working parents, children and teenagers get the support they need

 
 
Kim Darling, the CEO and Founder of Competitive Health (CHI), a provider of virtual healthcare access technologies and benefit management solutions again joins eHealth Radio and the Healthcare and Technology Channels.
Listen to interview with host Eric Michaels & guest Kim Darling discuss the following:
For many working parents and caregivers, balancing the demands of a full-time job and family can be overwhelming. How are children and teens being impacted?
What is the core problem with accessing Family Behavioral Health today?
How is Behavioral Health Care responding to the demand for therapy with Virtual Care.
How can employers support their employees with offering virtual behavioral health?
What resources are available to help guide employers and working parents?
Kim Darling, CEO and founder, Competitive Health
Kim is an entrepreneur and inventor who advocates for the practical use of technology. Having more that 30 years of healthcare and technology experience, Kim excels at consultatively finding unique value and solutions, and holds multiple U.S. Patents that advance innovation of healthcare data, payments and engagement.
About Competitive Health, Inc.
Founded in 1996, Competitive Health is the preeminent builder of custom health solutions. Utilizing award-winning digital health programs, 22 telehealth specialties, and healthcare ancillary services, providing unlimited access and unprecedented savings to our clients and their members. Last year – Competitive Health saved employer groups, insurance carriers, third-party administrators, affinity groups, and exchanges over $100 million dollars.
 
 
Website: https://competitivehealth.com 
Social Media Links: Twitter: https://twitter.com/CompHealthInc  Facebook: https://facebook.com/CompetitiveHealth  Linkedin: https://linkedin.com/company/competitive-health-inc. 

Virtual Care Solution to Support Behavioral Health Care in Post-Pandemic Era

 
 
Kim Darling, the CEO and Founder of Competitive Health (CHI), a provider of virtual healthcare access technologies and benefit management solutions joins eHealth Radio and the Healthcare and Technology Channels.
Listen to interview with host Eric Michaels & guest Kim Darling discuss the following:
What is driving the current demand for behavioral health care?
What do you see as needed to address America’s mental health crisis?
What is the greatest challenge to behavioral health support?
How are telehealth technologies supporting access to counseling and therapy?
How is CHI responding to challenges and barriers to accessing affordable, quality mental health services?
Kim Darling, CEO and founder, Competitive Health
Kim is an entrepreneur and inventor who advocates for the practical use of technology. Having more that 30 years of healthcare and technology experience, Kim excels at consultatively finding unique value and solutions, and holds multiple U.S. Patents that advance innovation of healthcare data, payments and engagement.
About Competitive Health, Inc.
Founded in 1996, Competitive Health is the preeminent builder of custom health solutions. Utilizing award-winning digital health programs, 22 telehealth specialties, and healthcare ancillary services, providing unlimited access and unprecedented savings to our clients and their members. Last year – Competitive Health saved employer groups, insurance carriers, third-party administrators, affinity groups, and exchanges over $100 million dollars.
 
 
Website: https://competitivehealth.com 
Social Media Links: Twitter: https://twitter.com/CompHealthInc  Facebook: https://facebook.com/CompetitiveHealth  Linkedin: https://linkedin.com/company/competitive-health-inc. 

Torque3 Launches Alpha Program to Evaluate Equipment Designed to Reinvent Stroke Rehabilitation

 
 
David Ellzey is CEO of Torque 3, an innovative stroke rehabilitation program using VR and motion simulation technology joins eHealth Radio and the Rehabilitation Information and Technology Channels.
Listen to interview with host Eric Michaels & guest David Ellzey discuss the following:
Please tell us about the genesis of Torque 3.
How does it differ from other stroke rehabilitation methods?
Tell us please about Task Oriented Therapy.
When are you running Torque3’s Alpha Lab?
Who are the candidates that would most likely benefit from Torque3?
Summary: Currently, neuro-rehabilitation for stroke survivors results in fewer than 10 percent resuming an active, independent lifestyle. This is where Torque3 can make a profound difference. Nothing like this stroke rehabilitation system exists anywhere.
David Ellzey is the CEO of Torque 3, an innovative stroke rehabilitation program using VR and motion simulation technology. He is a strategist, innovator, and design engineer with over 25 years of experience in creative concept development and effective design. His expertise spans business strategy, innovative technology, and goal-directed design with an extensive focus on delivering location-based, deeply immersive experiences. Technologies such as virtual reality, motion simulation, natural control systems, and game engines are all part of his toolkit.
 
 
Website: https://torque3.com 
Social Media Links: Instagram: https://instagram.com/vreemotion Facebook: https://facebook.com/Transformative.Stroke.Recovery Linkedin: https://linkedin.com/company/torque3 

OB/GYNs Look to New Reproductive Technology to Meet Demand for Achieving Pregnancy

 
 
Barbara Levy, Senior VP of Global Clinical Integration at INVO Bioscience, a medical technology company dedicated to making fertility care accessible and inclusive to people around the world joins eHealth Radio and the Fertility Information and Female Health Channels.
Listen to interview with host Eric Michaels & guest Barbara Levy discuss the following:
What is INVOcell?
Could you share a step by step overview of the device?
How does it compare to other fertility approaches? What is the success rate with IVC?
How often can INVOcell be used?
What age groups typically utilize INVOcell?
Can you provide insight on the price comparison to IVF?
What is the overall consensus on INVOcell in the OB/GYN community?
Where is INVOcell being used?
How many pregnancies have been conceived with INVOcell?

Barbara Levy is a key opinion leader within women’s healthcare and the OB/GYN community and serves as INVO Bioscience’s Senior VP Global Clinical Integration.
Prior to INVO, Barbara held the position of VP of Health Policy within the American College Of Gynecology (ACOG), worked in private practice in comprehensive holistic women’s health for over 30 years, and served as Medical Director for Women’s and Children’s Services for the Franciscan Health System in Washington State.
Barbara also has served as a reviewer and editor for several medical journals, including Obstetrics & Gynecology, American Journal of Obstetrics and Gynecology, JAMA, JMIG, and Fertility and Sterility. Her research interests span from outcomes research in minimally invasive gynecologic surgery to optimizing care for women with chronic pelvic pain. Her clinical work focused on evidence-based, equitable, comprehensive care for women throughout their life course. She has published and co-authored over 85 studies.
 
 
Website: https://invobioscience.com | https://invocell.com 
Social Media Links: Linkedin: https://linkedin.com/company/invo-bioscience Facebook: https://facebook.com/INVOBioscience Twitter: https://twitter.com/invobio_us 

JScreen.org saves lives – Give a Spit and get Genetic and Cancer Screenings!

 
 
Karen Grinzaid, Assistant Professor of Human Genetics and Executive Director of JScreen, a national online genetic disease screening program based out of Emory University School of Medicine joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Karen Grinzaid discuss the following:
What is JScreen exactly? How did the service come to be called JScreen?
How did it start – tell us about the couple that came to you in Atlanta and their story about their child and the inspiration behind JScreen?
How does it work for people who want to get Screened?
How does the testing work with your own doctors?
Who helps you understand the results – is there a doctor or Genetic Counselor who talks to you about the screening?
How long from when you order the tests until you receive results?
How many tests can you get at one time? What are the costs?
Since you are a non-profit – can people or groups donate to your organization and how to do so?
Karen Grinzaid is Assistant Professor of Human Genetics and Executive Director of JScreen, a national online genetic disease screening program based out of Emory University School of Medicine. She has extensive experience in genetic counseling and testing, clinical care and clinical research. Karen is proud of JScreen’s success in helping couples across the U.S. have healthy babies and in giving people the information they need to help prevent the devastating effects of hereditary cancer.
Karen received her B.A. in Psychology from Northwestern University and her M.S. in Human Genetics from Sarah Lawrence College. She is certified in Genetic Counseling by the American Board of Medical Genetics/American Board of Genetic Counseling and as a Clinical Research Coordinator through the Association of Clinical Research Professionals.
About JScreen
JScreen is a national non-profit public health initiative dedicated to preventing genetic diseases and hereditary cancer. Headquartered in Atlanta at Emory University School of Medicine, the JScreen initiative provides convenient at-home access to cutting-edge genetic testing technology, patient education and genetic counseling services. JScreen believes the combination of education, access to premier genetic screening technologies and personalized, confidential support are the keys to preventing devastating diseases.
Although both JScreen and direct to consumer DTC companies allow participants to screen at home. JScreen’s program is led by medical professionals at an academic medical center and provides medical grade testing that is used in doctor’s offices, as well as specialized genetic counseling via tele-health.
 
 
Website: https://www.jscreen.org  
Social Media Links: Facebook: @MyJScreen Instagram: @GetJScreened Twitter: @MyJScreen

Countifi: AI in Healthcare

 
 
David Hailey the CEO and Founder of Countifi (formally Countalytics), an image analysis and data analytics company that focuses on helping hospitals, airlines, and universities manage inventory processes more efficiently joins eHealth Radio and the Healthcare and Technology Channels.
Listen to interview with host Eric Michaels and guest David Hailey discuss the following:
Tell us about you and your expertise in this industry?
What’s the story behind Countifi?
Why is efficiency needed in the healthcare industry, and what does Countifi do?
Who - specifically - are you helping in the industry and in what ways are you helpful to them?
Share with us use cases of Countifi in the healthcare industry.
Talk about data analytics and the type of information that you can draw.
How long is the process from beginning to end? 

What financial considerations should be taken into account in utilizing Countifi?
David Hailey is the CEO and Founder of Countifi (formally Countalytics), an image analysis and data analytics company that focuses on helping hospitals, airlines, and universities manage inventory processes more efficiently. Countifi has worked with companies like Delta Airlines, Iberia Airlines, The Emirates Group, Duke Raleigh Hospital, and North Carolina A&T University, to name a few.
Before Countifi, David was a General Manager at Delta Air Lines, holding various management positions. Before that, he worked at EY for seven years holding positions in the external financial, internal audit, and consulting divisions in the Charlotte and Atlanta offices. David earned his bachelor's and master's degree in Accounting from North Carolina State University and an MBA from the Fugua School of Business at Duke University.
About Countifi
Counting inventory is manually intensive, expensive and usually full of mistakes. The Countifi team has worked with clients such as Delta Air Lines, Iberia Air,The Emirates Group, Emirates Air, Duke Raleigh Hospital and North Carolina A&T Real Estate Foundation. Our team is very hands-on to ensure we understand the nuances of our client's processes and implement the Countifi Platform to add value almost immediately.
The Countifi Al platform uses computer vision and deep learning to take pictures of inventory to automatically and accurately identify the items inside the image, saving time and money associated with manual inventory counts. The Countifi Platform reduces counting time and costs by 30%-40% during the first 12-24 months of implementation alone. As more images are gathered, the deep learning processes ensure accuracy rates average between 97% and 99%. The Al-based Countifi Inventory Management Platform uses cutting-edge computer vision and deep learning models to simplify the inventory counting and management process by adding transparency and accountability.
Website: https://countifi.com
Linkedin: https://linkedin.com/company/countifi 

Wellness Tech Company obVus Solutions on The Pandemic within the Pandemic

 
 
Ken Rosenblood, the Founder and CEO of obVus Solutions, a wellness tech company that develops award-winning products to change behavior and condition healthy habits joins eHealth Radio and Health News and Technology Channels. Ken founded obVus Solutions after a successful career as an attorney and as a C-level executive in the healthcare and technology fields. Ken has a proven successful track record of pioneering multi-billion dollar platforms and developing products and devices in practice-based healthcare.
Listen to interview with host Eric Michaels and guest Ken Rosenblood discuss the following:
Please tell me about yourself and how you came to be here today.
What inspired you to start obVus Solutions and what does your company offer?
What exactly is the “pandemic within the pandemic”?
How can technology address these issues within the Healthcare community?
Why is a wearable device such as “minder a benefit to Healthcare workers?
In closing, what is the one wellness tip you would offer to our listeners? 
Ken Rosenblood is founder and CEO of obVus Solutions, [pronounced “obvious”], a Los Angeles-based wellness tech company that develops user-friendly products to change behavior and condition healthy habits. Well-tech is the convergence of devices, tech and people. The obVus Solutions award-winning product line includes five-time patented minder,® a smart wearable that prompts proper breathing, posture and mindful breaks utilizing real-time biofeedback and certified health coaches; the minder Laptop Tower Stand, an ergonomically designed, height-adjustable that turns a laptop into sit/stand/desk; and the portable, folding Bluetooth minder® keyboard that serves as the portable companion to the minder Laptop Tower Stand. 
 As told to Authority Magazine in the 2020 article titled, “Getting an Upgrade: How Anyone Can Build Habits for Optimal Wellness, Performance and Focus,” Ken comes from a line of entrepreneurs, and was inspired to found obVus Solutions after a long successful career as an attorney and as a C-level executive in the healthcare and technology fields.
 “I’ve been fortunate enough to build on those skill sets and apply them to the founding of my own company, obVus Solutions. The inspiration for this company came after being plagued with health issues, thanks to too many long hours behind a computer and sitting at a desk, where I didn’t give much priority to my posture, stress levels or breathing habits. Those behaviors took a severe toll on my health, eventually leading me to surgery followed by a long, painful recovery period.  I knew there were many others, like me, who were experiencing the same. That inspired me to develop a range of ergonomically-designed wellness products that can help people work and live better” says Ken.
 A 30-year technology and healthcare veteran, Ken has a proven successful track record of pioneering multi-billion dollar platforms and developing products and devices in practice-based healthcare.  Ken has had multiple successful exits from previous ventures in recurring revenue, PaaS, SaaS businesses.
 “As more consumers are tasked with finding ways to work and study remotely, obVus Solutions will lead the wellness journey by helping consumers build better habits, from practicing good posture and nutrition to the management of stress and other healthy behaviors,” says Ken.
About obVus Solutions
obVus Solutions (pronounced “obvious”) is a Los Angeles-based wellness tech company that develops award-winning products and services to coach and condition healthy habits. Its flagship patented product, minder®, is a smart wearable device that offers real-time insight to build healthy habits. minder was awarded “Best App” in 2021 by the Webby Awards; and “Best Mobile Product” at the 11th Annual Media Excellence Awards, which honors innovation and leadership. Users have the option to add one on one sessions with certified minder health coaches, called minderPROs, providing valuable support.  The obVus minder® Laptop Tower Stand, an ergonomically designed, height-adjustable stand that turns a laptop into a sit/stand desk, was named “The Best Laptop Stand to Save Your Neck” by Wired magazine and a 2021 “Best Healthy Home Product” by Health Magazine.  Pair the Laptop Tower Stand with the minder wireless, portable keyboard for a high-comfort, ergonomically correct work environment that supports wellness and drives productivity.
Website: https://obvus.me
Social Media Links: Facebook: https://facebook.com/obvussolutions Instagram: https://instagram.com/obvussolutions 

Taking Control of Germs in the Palm of Your Hand with UVCeed

 
 
Dr. Peter Bonutti, M.D., the Co-founder & CEO of UVCeed, a smart UVC disinfection system to help limit the spread of infections, particularly COVID-19 joins eHealth Radio and the COVID-19 Information and Disinfection Channels. Dr. Bonutti is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience.
Listen to interview with host Eric Michaels and guest Dr. Peter Bonutti discuss the following:
As an MD why did you see the need to create a UV disinfection solution for consumers?
What is the problem you are solving? What is the science behind UVCeed? How does it work?
What are some of the most common uses for the product?
UVCeed eliminates 99.9 of the germs including Covid-19. Does this eliminate the need for face masks and sanitizers now?
Where can our audience get the app and the device today?
Dr. Peter Bonutti, M.D. is co-founder & CEO of UVCeed. He created the smart UVC disinfection system to help limit the spread of infections, particularly COVID-19.
Dr. Bonutti is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience. He is the founder of Bonutti Research, a medical device incubator that has developed products and technology used around the world, including UVCeed, and maintains his clinical and surgical practice, focusing on adult knee and hip arthroplasty and integration of robotics into surgical procedures.
Dr. Bonutti is a pioneer in Minimally Invasive Surgery, has over 500 patents and applications, more than 700 licenses and multiple FDA-approved products to date. Major corporations leveraging his technology include Hitachi, Medtronic, Kyphon, Covidien, US Surgical, Biomet, Arthrocare, Synthes, Zimmer/Biomet and Stryker. He is a prolific speaker, lecturing internationally, and has trained over 100 surgeons on his surgical techniques.
In his career, Dr. Bonutti has received more than a dozen industry honors and awards for his achievements. Dr. Bonutti earned his medical degree at University of Cincinnati College of Medicine and completed his Orthopaedic Surgery Residency at Cleveland Clinic Foundation with international fellowships in Canada, Australia, and Austria.
 
 
Website: https://uvceed.com 
Social Media Links: Instagram: https://instagram.com/uvceedsanitizer  Linkedin: https://linkedin.com/company/bonutti-technologies/about 
 

Dr. Martin M. Grajower, discusses innovations to help both physicians and patients fight the silent epidemic of fatty liver disease

 
 
Dr. Martin M. Grajower, M.D., FACP, FACE, a Clinical Professor of Medicine, Division of Endocrinology, at Albert Einstein College of Medicine, Bronx, New York, joins eHealth Radio and the Health News and Technology Channels to discuss innovations to help both physicians and patients fight the silent epidemic of fatty liver disease.
Listen to interview with host Eric Michaels and guest Dr. Martin M. Grajower discuss the following:
What are the main risk factors for nonalcoholic fatty liver disease (NAFLD)?
Can you explain the role that obesity plays in connection with NAFLD and diabetes?
What are the health risks associated with having NAFLD?
At what point should endocrinologists screen for NAFLD in patients with Type 2 diabetes?
Can you provide an example of how endocrinologists can help their patients who are at risk for liver disease?
Martin Grajower MD FACP FACE is an endocrinologist in the Bronx, New York, and is affiliated with Montefiore Medical Center and Columbia University Hospital of Physicians and Surgeons. He received his medical degree from Albert Einstein College of Medicine and has been in private practice for over 40 years. He holds the title of Clinical Professor of Medicine, Division of Endocrinology, at Albert Einstein College of Medicine.
 
About Echosens
Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.
 
 
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV Twitter: twitter.com/Echosens

Former Hernia Surgeon, Dr. Freedman, turned patient advocate shares advice for avoiding mesh and no mesh misconceptions

 
 
Dr. Bruce Freedman, Vice President of Clinical Development at TELA Bio, a medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in hernia repairs joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Dr. Bruce Freedman discuss the following:
What are the current challenges with hernia repairs?
What are the most common concerns patients have about their hernia repair?
What is the difference between mesh and no mesh hernia repair?
What are the questions patients should be asking their doctors about hernia repair?
Where can patients go to learn more about their hernia repair treatment options?
Bruce Freedman, M.D., FACS is the Vice President of Clinical Development at TELA Bio. After 32 years as a private practice general surgeon specializing in hernia repair and abdominal wall reconstruction, Dr. Freedman joined TELA Bio in 2021 to advocate for a more natural hernia repair mesh option as an alternative to permanent and resorbable synthetic mesh. In his role, Dr. Freedman utilizes his extensive experience as a healthcare provider to share the clinical and financial benefits of the OviTex Reinforced Tissue Matrix portfolio with surgeons and hospital administration.
Websites: https://TELABio.com | https://abouthernia.com 
Social Media Links: Facebook: https://facebook.com/telabioinc  Instagram: https://instagram.com/telabio LinkedIn: https://linkedin.com/company/tela-bio Twitter: https://twitter.com/TELABioInc